Szymon Gorgoń

Biochemistry, Genetics and Molecular Biology · Life Sciences

6h-index319citations46works0.22yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Genetics, Aging, and Longevity in Model Organisms(32), Invertebrate Taxonomy and Ecology(8), Parasite Biology and Host Interactions(5), Leech Biology and Applications(4), Marine Biology and Ecology Research(3)

Publications46 total

Figure S2 from A Drug Discovery Pipeline for MAPK/ERK Pathway Inhibitors in <i>Caenorhabditis elegans</i>
2025Open Access
Supp methods and figure legends from A Drug Discovery Pipeline for MAPK/ERK Pathway Inhibitors in <i>Caenorhabditis elegans</i>
2025Open Access
Figure S3 from A Drug Discovery Pipeline for MAPK/ERK Pathway Inhibitors in <i>Caenorhabditis elegans</i>
2025Open Access
Table S1 from A Drug Discovery Pipeline for MAPK/ERK Pathway Inhibitors in <i>Caenorhabditis elegans</i>
2025Open Access
Figure S4 from A Drug Discovery Pipeline for MAPK/ERK Pathway Inhibitors in <i>Caenorhabditis elegans</i>
2025Open Access
Figure S1 from A Drug Discovery Pipeline for MAPK/ERK Pathway Inhibitors in <i>Caenorhabditis elegans</i>
2025Open Access
Figure S3 from A Drug Discovery Pipeline for MAPK/ERK Pathway Inhibitors in <i>Caenorhabditis elegans</i>
2024Open Access
Figure 5 from A Drug Discovery Pipeline for MAPK/ERK Pathway Inhibitors in <i>Caenorhabditis elegans</i>
2024Open Access
Figure 2 from A Drug Discovery Pipeline for MAPK/ERK Pathway Inhibitors in <i>Caenorhabditis elegans</i>
2024Open Access
Figure S1 from A Drug Discovery Pipeline for MAPK/ERK Pathway Inhibitors in <i>Caenorhabditis elegans</i>
2024Open Access
Figure 2 from A Drug Discovery Pipeline for MAPK/ERK Pathway Inhibitors in <i>Caenorhabditis elegans</i>
2024Open Access
Figure S1 from A Drug Discovery Pipeline for MAPK/ERK Pathway Inhibitors in <i>Caenorhabditis elegans</i>
2024Open Access
Supp methods and figure legends from A Drug Discovery Pipeline for MAPK/ERK Pathway Inhibitors in <i>Caenorhabditis elegans</i>
2024Open Access
Figure 5 from A Drug Discovery Pipeline for MAPK/ERK Pathway Inhibitors in <i>Caenorhabditis elegans</i>
2024Open Access
Figure 6 from A Drug Discovery Pipeline for MAPK/ERK Pathway Inhibitors in <i>Caenorhabditis elegans</i>
2024Open Access
Figure S2 from A Drug Discovery Pipeline for MAPK/ERK Pathway Inhibitors in <i>Caenorhabditis elegans</i>
2024Open Access
Data from A Drug Discovery Pipeline for MAPK/ERK Pathway Inhibitors in <i>Caenorhabditis elegans</i>
2024Open Access
Table S1 from A Drug Discovery Pipeline for MAPK/ERK Pathway Inhibitors in <i>Caenorhabditis elegans</i>
2024Open Access
Figure S3 from A Drug Discovery Pipeline for MAPK/ERK Pathway Inhibitors in <i>Caenorhabditis elegans</i>
2024Open Access
Figure 4 from A Drug Discovery Pipeline for MAPK/ERK Pathway Inhibitors in <i>Caenorhabditis elegans</i>
2024Open Access
page 1 of 3Next →

Frequent Co-authors

Ola Billing(31), Anna U. Eriksson(31), Oskar Hemmingsson(31), Piotr Świątek(11), Anna Z. Urbisz(5), Mariola Krodkiewska(5), Karol Małota(3), Agata Wardas(3), Bartosz J. Płachno(2), L. C. Marchant(2), Natalia Jarosz(2), Agnieszka Włodarczyk(1), Adrian Radoń(1), Karolina Bajdak-Rusinek(1), Saška Lipovšek(1), Gerd Leitinger(1), Tone Novak(1), Franc Janžekovič(1), K Kamińska(1), Magdalena Rost–Roszkowska(1)